SCHEMBL12818063

SCHEMBL12818063

COc1ncc(-c2ccc3c(c2)N(S(=O)(=O)c2ccc4[nH]c(=O)[nH]c4c2)CCO3)cn1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ PKM P14618 1/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42
▸ PDE3B Q13370 4/20 0.40
▸ PDE3A Q14432 4/20 0.40
▸ MEN1 O00255 3/20 0.40
▸ KMT2A Q03164 3/20 0.40
▸ MAPT P10636 2/20 0.40
▸ TP53 P04637 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ ATM Q13315 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ POLB P06746 1/20 0.39
▸ CPT1A P50416 1/20 0.39
▸ CPT1B Q92523 1/20 0.39
▸ PIK3CD O00329 4/20 0.36
▸ RIPK2 O43353 1/20 0.36
▸ NOD2 Q9HC29 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12818233 0.86 PDE3B (0.42) NPC1CYP2C9PKMTDP1PDE3B
SCHEMBL12818601 0.83 PDE3B (0.49) NPC1CYP2C9PKMTDP1PDE3B
SCHEMBL12818991 0.80 PKM (0.43) NPC1CYP2C9PKMTDP1PDE3B
SCHEMBL12818812 0.79 CYP2C9 (0.43) NPC1CYP2C9PKMPDE3BPDE3A
SCHEMBL12817592 0.79 PKM (0.44) NPC1CYP2C9PKMTDP1PDE3B
SCHEMBL12818102 0.79 BRD4 (0.45) CYP2C9PKMTDP1PDE3BPDE3A
SCHEMBL12818620 0.78 LMNA (0.42) NPC1CYP2C9PKMMEN1KMT2A
SCHEMBL12818687 0.78 PKM (0.40) NPC1CYP2C9PKMTDP1PDE3B
SCHEMBL12818616 0.78 PKM (0.40) CYP2C9PKMTDP1PDE3BPDE3A
SCHEMBL12818391 0.78 PKM (0.43) NPC1CYP2C9PKMTDP1PDE3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012130306-A1 BICYCLIC 2,3-DIHYRDOBENZAZINE COMPOUNDS FOR USE IN THERAPY ELARA PHARMACEUTICALS GMBH (DE) 2012-10-04 — — WO disclosed
Send feedback